An Open-Label, Multicenter, Phase I, Dose Escalation Study with Phase II Expansion Cohort to Determine the Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Intravenous TKM-080301 in Subjects with Advanced Hepatocellular Carcinoma
Journal
Oncologist
Journal Volume
24
Journal Issue
6
Pages
747-e218
Date Issued
2019
Author(s)
El Dika I.
Lim H.Y.
Yong W.P.
Yoon J.-H.
Modiano M.
Freilich B.
Choi H.J.
Chao T.-Y.
Kelley R.K.
Brown J.
Knox J.
Ryoo B.-Y.
Yau T.
Abou-Alfa G.K.
Publisher
Wiley-Blackwell
Type
journal article